Short Interest in Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) Expands By 2,523.8%

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) saw a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 55,100 shares, an increase of 2,523.8% from the January 15th total of 2,100 shares. Based on an average daily volume of 171,000 shares, the days-to-cover ratio is currently 0.3 days.

Enzon Pharmaceuticals Trading Down 6.9 %

ENZN stock traded down $0.01 during mid-day trading on Wednesday, reaching $0.16. The company’s stock had a trading volume of 32,220 shares, compared to its average volume of 62,793. The company has a market cap of $12.02 million, a price-to-earnings ratio of 16.22 and a beta of 0.26. The business’s 50 day moving average price is $0.15 and its 200 day moving average price is $0.13. Enzon Pharmaceuticals has a 12 month low of $0.06 and a 12 month high of $0.24.

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.